Form 4: Ginkgo Bioworks Director Receives Stock Units

Sentiment:

Insider Transaction


Ginkgo Bioworks Holdings, Inc. Director Kosuri Sri was granted 25,000 restricted stock units under the company's Non-Employee Director Compensation Program.

Summary

  • Kosuri Sri, a Director at Ginkgo Bioworks Holdings, Inc., received 25,000 restricted stock units (RSUs) on June 11, 2026.
  • These RSUs are part of the company's Amended and Restated Non-Employee Director Compensation Program.
  • The RSUs are set to vest on the earlier of June 11, 2027, or the day before the next Annual Meeting, provided the director remains in service.
  • Each RSU represents a contingent right to receive one share of the Issuer's Class A Common Stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard compensation grant to a director rather than a significant financial event or strategic shift.

Positives

  • Director compensation aligns with company stock performance through RSUs.
  • Clear vesting schedule tied to continued service and annual meetings.

Risks

  • Vesting is contingent on continued service as a Non-Employee Director.
  • The value of the RSUs is subject to the market performance of Ginkgo Bioworks' Class A Common Stock.

Future Outlook

The RSUs will vest on the earlier of June 11, 2027, or the day immediately prior to the date of the next Annual Meeting, subject to the Reporting Person continuing in service as a Non-Employee Director through such vesting date.

Industry Context

StockSavvy.ai notes that the issuance of Restricted Stock Units (RSUs) to directors is a common practice in the biotechnology and synthetic biology sectors, aligning director compensation with shareholder interests and long-term company performance.

Corporate Governance

Change TypeDescriptionEffective DateImpact Assessment
Director Compensation Program UpdateThe grant of RSUs is made in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Program.06/11/2026Standardizes and formalizes director compensation, aligning incentives with long-term shareholder value.

Stakeholder Impact

  • Shareholders: The RSU grant aligns director incentives with the company's stock performance, potentially benefiting shareholders if the stock price increases.
  • Directors: Provides a form of compensation tied to company performance and continued service.

Next Steps

  • Kosuri Sri must continue in service as a Non-Employee Director through the vesting date for the RSUs to vest.
  • The RSUs will vest on the earlier of June 11, 2027, or the day before the next Annual Meeting.

Key Dates

DateDescription
06/11/2026Date of earliest transaction; grant date of Restricted Stock Units.
06/11/2027Earliest possible vesting date for the Restricted Stock Units.
06/15/2026Date the Form 4 was signed.

Keywords

Ginkgo Bioworks, DNA, Form 4, SEC Filing, Restricted Stock Units, RSU, Director Compensation, Equity Award, Insider Trading, Beneficial Ownership

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.